A first-of-its-kind osteoporosis drug lowers the risk of bone fractures better than some existing treatments, two studies suggest, and soon could add a more expensive but easier-to-manage treatment ...

Boston-based Beth Israel Deaconess Medical Center played a role in a new FDA decision that allows bone mineral density, measured through noninvasive imaging, to serve as a qualified endpoint in ...

The study included 44,338 matched pairs of patients who were treated with bisphosphonates, denosumab, raloxifene, or teriparatide and those who did not receive any of these treatments. HealthDay News ...

FDA qualification of Total Hip BMD as a validated surrogate endpoint for novel osteoporosis drug development further bolsters Entera's July 2025 ...

People who are older than 80 should be considered for osteoporosis treatment after a fracture to avoid further risk, according to a study being presented Saturday at ENDO 2025, the Endocrine Society's ...

Osteoporosis treatment following fragility fracture was associated with significantly reduced hospitalization and mortality risks among patients aged 80 years and older. After fracture at 80 years of ...

Because osteoporosis is more prevalent in women, men with osteoporosis often are overlooked. According to the NIH, men are less likely than women to be evaluated for osteoporosis after a fracture, and ...

Some of the most commonly used medications for osteoporosis can lead to osteonecrosis of the jaw (ONJ), a rare but serious side effect. "Inflammation and infection [in the mouth] plus a potent ...

Postmenopausal women and men over 50 years of age. Clinical data on this first group of patients are very scarce because of difficulties in fracture risk assessment, owing to the lack of reliable ...

SAN FRANCISCO—People who are older than 80 should be considered for osteoporosis treatment after a fracture to avoid further risk, according to a study being presented Saturday at ENDO 2025, the ...